MAP-2 immunoexpression in gliomatosis cerebri

Histopathology

Volumn 54, Issue 4, 2009, Pages 504-505

  Romeike, Bernd F M ^a   Mawrin, Christian ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; MONOCLONAL ANTIBODY;

ASTROCYTE; CONTROLLED STUDY; GLIOMA; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LETTER; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS, NEUROEPITHELIAL; TUMOR MARKERS, BIOLOGICAL;

EID: 62149115186     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03236.x     Document Type: Letter

References (6)

1. Blümcke I, Müller S, Buslei R, Riederer BM, Wiestler OD. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol. 2004 108 89 96.
2. Romeike BF, Mawrin C. Gliomatosis cerebri: growing evidence for diffuse gliomas with wide invasion. Expert Rev. Neurother. 2008 8 587 597.
3. Fuller GN, Kros JM. Gliomatosis cerebri. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK eds. WHO classification of tumours of the central nervous system, 4th edn. Lyon : IARC Press, 2007 50 52.
4. Mawrin C, Kirches E, Schneider-Stock R et al. Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol. 2003 105 529 536.
5. Mawrin C, Kirches E, Schneider-Stock R et al. Alterations of cell cycle regulators in gliomatosis cerebri. J. Neurooncol. 2005 72 115 122.
6. Mawrin C, Schneider T, Firsching R et al. Assessment of tumor cell invasion factors in gliomatosis cerebri. J. Neurooncol. 2005 73 109 115.